Biblio Discovery — Demo Discovery Service

16 hasil

Menampilkan 1–16 · 0,85 detik · RSS

Jurnal

Drugs

Scopus

ISSN 0012-6667 · Adis, Springer Healthcare · 16 artikel di indeks

  1. Artikel Jurnal

    Resmetirom: First Approval

    Susan J. Keam

    Drugs · 2024 · Inggris · OpenAlex Scopus

  2. Artikel Jurnal Teks lengkap

    Androgenetic Alopecia: Therapy Update

    Shivali Devjani; Ogechi Ezemma; Kristen Joan Kelley dkk.

    Drugs · 2023 · Inggris · OpenAlex Scopus

  3. Artikel Jurnal Teks lengkap

    Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics

    Jeffrey L. Cummings

    Drugs · 2023 · Inggris · OpenAlex Scopus

    )-have been approved in the USA for the treatment of Alzheimer's disease (AD). Anti-amyloid monoclonal antibodies are the first disease-modifying therapies for AD that achieve slowing of clinical decline by intervening in the basic biological processes of the disease. These are breakthrough agents…

  4. Artikel Jurnal Teks lengkap

    Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection

    Sahil Khanna; Maha Assi; Christine U. Lee dkk.

    Drugs · 2022 · Inggris · OpenAlex Scopus

    Recurrent Clostridioides difficile infection, associated with dysbiosis of gut microbiota, has substantial disease burden in the USA. RBX2660 is a live biotherapeutic product consisting of a broad consortium of microbes prepared from human stool that is under investigation for the reduction of…

  5. Artikel Jurnal Teks lengkap

    Nirmatrelvir Plus Ritonavir: First Approval

    Yvette N. Lamb

    Drugs · 2022 · Inggris · OpenAlex Scopus

    Nirmatrelvir plus ritonavir (Paxlovid™; Pfizer) is a co-packaged combination of nirmatrelvir and ritonavir tablets, intended for co-administration and developed for the treatment and post-exposure prophylaxis of coronavirus disease 2019 (COVID-19). Nirmatrelvir is a peptidomimetic inhibitor of the…

  6. Artikel Jurnal Teks lengkap

    Prevention and Treatment of Monkeypox

    John G. Rizk; Giuseppe Lippi; Brandon Michael Henry dkk.

    Drugs · 2022 · Inggris · OpenAlex Scopus

  7. Artikel Jurnal Teks lengkap

    Acute Pancreatitis: Diagnosis and Treatment

    Peter Szatmary; Tassos Grammatikopoulos; Wenhao Cai dkk.

    Drugs · 2022 · Inggris · OpenAlex Scopus

    Acute pancreatitis is a common indication for hospital admission, increasing in incidence, including in children, pregnancy and the elderly. Moderately severe acute pancreatitis with fluid and/or necrotic collections causes substantial morbidity, and severe disease with persistent organ failure…

  8. Artikel Jurnal Teks lengkap

    Inclisiran: First Approval

    Yvette N. Lamb

    Drugs · 2021 · Inggris · OpenAlex Scopus

    ; Novartis) is a first-in-class, cholesterol-lowering small interfering RNA (siRNA) conjugated to triantennary N-acetylgalactosamine carbohydrates (GalNAc). Inclisiran received its first approval in December 2020 in the EU for use in adults with primary hypercholesterolaemia (heterozygous familial…

  9. Artikel Jurnal Teks lengkap

    BNT162b2 mRNA COVID-19 Vaccine: First Approval

    Yvette N. Lamb

    Drugs · 2021 · Inggris · OpenAlex Scopus

  10. Artikel Jurnal Teks lengkap

    The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin

    Martin Hoenigl; Rosanne Sprute; Matthias Egger dkk.

    Drugs · 2021 · Inggris · OpenAlex Scopus

    The epidemiology of invasive fungal infections is changing, with new populations at risk and the emergence of resistance caused by the selective pressure from increased usage of antifungal agents in prophylaxis, empiric therapy, and agriculture. Limited antifungal therapeutic options are further…

  11. Artikel Jurnal Teks lengkap

    Sotorasib: First Approval

    Hannah A. Blair

    Drugs · 2021 · Inggris · OpenAlex Scopus

    ) is a RAS GTPase family inhibitor being developed by Amgen for the treatment of solid tumours with KRAS mutations, including non-small cell lung cancer (NSCLC) and colorectal cancer. In May 2021, sotorasib was granted accelerated approval by the US FDA for the treatment of adult patients with KRAS…

  12. Artikel Jurnal Teks lengkap

    Sacituzumab Govitecan: First Approval

    Yahiya Y. Syed

    Drugs · 2020 · Inggris · OpenAlex Scopus

  13. Artikel Jurnal Teks lengkap

    Inhibiting CDK4/6 in Breast Cancer with Palbociclib, Ribociclib, and Abemaciclib: Similarities and Differences

    C. Louwrens Braal; Elisabeth M. Jongbloed; Saskia M. Wilting dkk.

    Drugs · 2020 · Inggris · OpenAlex Scopus

    The cyclin-dependent kinase (CDK) 4/6 inhibitors belong to a new class of drugs that interrupt proliferation of malignant cells by inhibiting progression through the cell cycle. Three such inhibitors, palbociclib, ribociclib, and abemaciclib were recently approved for breast cancer treatment in…

  14. Artikel Jurnal Teks lengkap

    Pharmaco-Immunomodulatory Therapy in COVID-19

    John G. Rizk; Kamyar Kalantar‐Zadeh; Mandeep R. Mehra dkk.

    Drugs · 2020 · Inggris · OpenAlex Scopus

  15. Artikel Jurnal Teks lengkap

    Remdesivir: First Approval

    Yvette N. Lamb

    Drugs · 2020 · Inggris · OpenAlex Scopus